A collection of genome-edited induced pluripotent stem cells (iPSCs) including reporter lines and cells with disease-associated SNPs, available for order with a simple license.

A service that performs custom genome editing using Bayspair's Scarless Editing technology, enabling various genome modifications with high success rates on a contingency fee basis.